The Latest Breaking News from FDA

For men, FDA-approved medications like Minoxidil, the generic for Rogaine®, offer a safe and effective solution for hair loss.

The European Union (EU) has announced a 32 million euro initiative aimed at enhancing vaccine production in Ghana. The announcement was made during the Ghana-EU Business Forum held in Accra.

FDA warns of lead contamination in ground cinnamon sold at discount stores. Consumers advised to discard affected products to avoid health risks.

Overdoses may have arisen from patients with poor knowledge of drug measurements and medical equipment, such as syringes, according to public health officials

Down 84% from all-time highs, Compass Pathways is a beaten-down biotech stock that trades at a massive discount to consensus price target estimates in 2024.

Scientists hope a new blood test for colorectal cancer could improve screening rates.

With the FDA's approval, it is very likely that private insurance companies and Medicare will cover the cost of the blood test, making it more accessible for patients.

A rise in counterfeit versions of sought-after weight loss drug has led to a series of hospitalisations.

FDA approves Guardant's Shield test for colon cancer screening in adults aged 45 and above, providing a convenient and accessible method for early detection.

The drugmaker Teva Pharmaceuticals made history in June by launching the first-ever generic version of a GLP-1 diabetes drug.

The biotech industry is experiencing rapid growth owing to new drug innovations and advancements in healthcare. To capitalize on the industry's expansion, it could be wise to invest in solid biotech stocks, Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), and Gilead Sciences (GILD), which have revolutionary pipelines. Read on….